clioquinol has been researched along with Brain Disorders in 7 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "They resemble transient global amnesia (TGA) of the classic type, but the episodes last longer (1-3 days), they are often accompanied by a variety of mental disturbances, and the onset and end are less well defined than in the classic type." | 6.37 | Transient global amnesia due to clioquinol. ( Kaeser, HE, 1984) |
| "They resemble transient global amnesia (TGA) of the classic type, but the episodes last longer (1-3 days), they are often accompanied by a variety of mental disturbances, and the onset and end are less well defined than in the classic type." | 2.37 | Transient global amnesia due to clioquinol. ( Kaeser, HE, 1984) |
| " The onset of all manifestations (except toxic encephalopathy) was usually subacute, with subsequent partial recovery." | 1.26 | Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. ( Baumgartner, G; Gawel, MJ; Kaeser, HE; Pallis, CA; Rose, FC; Schaumburg, HH; Thomas, PK; Wadia, NH, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pollera, C | 1 |
| Lucchini, B | 1 |
| Formentin, E | 1 |
| Bareggi, S | 1 |
| Poli, G | 1 |
| Ponti, W | 1 |
| Kaeser, HE | 2 |
| Buchanan, DS | 1 |
| Krinke, G | 1 |
| Schaumburg, HH | 2 |
| Spencer, PS | 1 |
| Thomann, P | 1 |
| Hess, R | 1 |
| Baumgartner, G | 1 |
| Gawel, MJ | 1 |
| Pallis, CA | 1 |
| Rose, FC | 1 |
| Thomas, PK | 1 |
| Wadia, NH | 1 |
| Ferrier, TM | 1 |
| Eadie, MJ | 1 |
1 review available for clioquinol and Brain Disorders
| Article | Year |
|---|---|
Transient global amnesia due to clioquinol.
Topics: Acute Disease; Adult; Aged; Amnesia; Amnesia, Retrograde; Brain Diseases; Clioquinol; Confusion; Fem | 1984 |
6 other studies available for clioquinol and Brain Disorders
| Article | Year |
|---|---|
Evaluation of anti-prionic activity of clioquinol in an in vivo model (Mesocricetus auratus).
Topics: Animals; Anti-Infective Agents; Brain Diseases; Central Nervous System; Clioquinol; Cricetinae; Dise | 2005 |
Idiosyncratic neurotoxicity: clioquinol and bismuth.
Topics: Austria; Bismuth; Brain Diseases; Clioquinol; Dose-Response Relationship, Drug; France; Humans; Japa | 1980 |
Iatrogenic causes of neurologic disorders: part 1. Affect, convulsions, and encephalopathies.
Topics: Affective Symptoms; Aged; Antiparkinson Agents; Brain Diseases; Clioquinol; Cognition Disorders; Hum | 1978 |
Clioquinol and 2,5-hexanedione induce different types of distal axonopathy in the dog.
Topics: Animals; Axons; Brain; Brain Diseases; Clioquinol; Dogs; Ketones; Methyl n-Butyl Ketone; Microscopy, | 1979 |
Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.
Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Clioquinol; Dose-Response Relation | 1979 |
Clioquinol encephalopathy.
Topics: Adult; Brain Diseases; Clioquinol; Cognition Disorders; Female; Headache; Humans; Male; Memory Disor | 1973 |